A Distinct Nasal Microbiota Signature in Peritoneal Dialysis Patients
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Hasegawa K, Linnemann R, Mansbach J, Ajami N, Espinola J, Petrosino J
. Nasal Airway Microbiota Profile and Severe Bronchiolitis in Infants: A Case-control Study. Pediatr Infect Dis J. 2016; 36(11):1044-1051.
PMC: 5479744.
DOI: 10.1097/INF.0000000000001500.
View
2.
Straub D, Blackwell N, Langarica-Fuentes A, Peltzer A, Nahnsen S, Kleindienst S
. Interpretations of Environmental Microbial Community Studies Are Biased by the Selected 16S rRNA (Gene) Amplicon Sequencing Pipeline. Front Microbiol. 2020; 11:550420.
PMC: 7645116.
DOI: 10.3389/fmicb.2020.550420.
View
3.
. Nasal mupirocin prevents Staphylococcus aureus exit-site infection during peritoneal dialysis. Mupirocin Study Group. J Am Soc Nephrol. 1996; 7(11):2403-8.
DOI: 10.1681/ASN.V7112403.
View
4.
Ewels P, Peltzer A, Fillinger S, Patel H, Alneberg J, Wilm A
. The nf-core framework for community-curated bioinformatics pipelines. Nat Biotechnol. 2020; 38(3):276-278.
DOI: 10.1038/s41587-020-0439-x.
View
5.
Luzar M, Coles G, Faller B, Slingeneyer A, Dah G, Briat C
. Staphylococcus aureus nasal carriage and infection in patients on continuous ambulatory peritoneal dialysis. N Engl J Med. 1990; 322(8):505-9.
DOI: 10.1056/NEJM199002223220804.
View